Why is Bliss GVS Pharma falling/rising?

As of 28-Aug, Bliss GVS Pharma Ltd is experiencing a decline in its stock price, currently at Rs 160.10, which reflects a decrease of Rs 2.75 or 1.69%. The stock has underperformed its sector today by 0.85%, reaching an intraday low of Rs 158.3. Over the past week, the stock has decreased by 2.02%, while it has shown a modest increase of 3.22% over the last month. Despite generating a return of 25.47% over the past year, the company's profits have fallen by 3.6%, and the stock is trading at a premium compared to its peers. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 31.21% against the five-day average, indicating reduced trading interest.
In the broader market context, the stock's recent performance has been relatively better than the benchmark Sensex, which has declined by 2.34% over the past week. However, the stock's year-to-date performance shows a decline of 2.76%, contrasting with the Sensex's gain of 2.48%. While Bliss GVS Pharma has demonstrated strong long-term performance, outperforming the BSE500 over the last three years, the current downward trend in price and falling investor participation suggest a cautious sentiment among investors in the short term.